This quality improvement/assessment program is designed to assist in optimizing surgeon performance and improving patient outcomes in Adolescent Idiopathic Scoliosis (AIS) surgery. Through participation in the AIS Quality Improvement Registry, surgeon participants will receive real-time reporting thru ‘dashboard reports’. Reporting contains comparative practice data that supports the identification of best practices and shared learning. In addition, participation in this program will allow educational opportunities through program supported surgeon education events.
Setting Scoliosis Straight Foundation is sponsoring this Surgeon Performance Program.
The mission of Setting Scoliosis Straight is: “To better discoveries and advance techniques, in the treatment of spinal deformities in children and adolescents worldwide.”
One of our organizational strategic goals is: “To improve quality, safety and uniform outcomes for scoliosis patients by being the leading resource globally for the standard of care and best practices for institutions and practicing surgeons”. This program will function as a vital strategy to meet our goals and ultimately fulfill our mission.
Through generous support from our industry partners, Medtronic, Inc. and NuVasive, Inc. Setting Scoliosis Straight is able to offer participation in this program and QI Registry to surgeons worldwide, free of charge.
Adolescent Idiopathic Scoliosis Quality Improvement Registry
This quality improvement (QI) registry was designed to assess patient and surgeon variables and practice patterns associated with the surgical treatment of Adolescent Idiopathic Scoliosis (AIS). Patient-level data is submitted by participating surgeons on a quarterly basis to the Setting Scoliosis Straight central infrastructure. The primary aims of this AIS QI registry are to promote health care quality improvement by allowing clinicians to identify ways to improve treatment processes and patient outcomes by tracking their surgical cases. The secondary aim of the AIS QI registry is to serve as a source of data for outcomes and comparative effectiveness research.